BDBM290372 (3R,4S)-3-amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid::US10098902, Example 8::US10603330, Example 8
SMILES: N[C@]1(CNC[C@@H]1CCCB(O)O)C(O)=O
InChI Key: InChIKey=NDZPRHZISXYFRQ-XPUUQOCRSA-N
Data: 6 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arginase-1 (Homo sapiens (Human)) | BDBM290372 ((3R,4S)-3-amino-4-(3-boronopropyl)pyrrolidine-3-ca...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 625 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Mars, Incorporated US Patent | Assay Description Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp... | US Patent US10098902 (2018) BindingDB Entry DOI: 10.7270/Q2319XXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Arginase-2, mitochondrial (Homo sapiens (Human)) | BDBM290372 ((3R,4S)-3-amino-4-(3-boronopropyl)pyrrolidine-3-ca...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 625 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Mars, Incorporated US Patent | Assay Description Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp... | US Patent US10098902 (2018) BindingDB Entry DOI: 10.7270/Q2319XXK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Arginase-1 (Homo sapiens (Human)) | BDBM290372 ((3R,4S)-3-amino-4-(3-boronopropyl)pyrrolidine-3-ca...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
New England Discovery Partners Curated by ChEMBL | Assay Description Inhibition of human recombinant arginase 1 expressed in Escherichia coli BL21 (DE3) assessed as reduction in urea production using L-arginine as subs... | J Med Chem 62: 8164-8177 (2019) Article DOI: 10.1021/acs.jmedchem.9b00931 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Arginase-2, mitochondrial (Homo sapiens (Human)) | BDBM290372 ((3R,4S)-3-amino-4-(3-boronopropyl)pyrrolidine-3-ca...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Mars, Incorporated US Patent | Assay Description Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp... | US Patent US10603330 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Arginase-1 (Homo sapiens (Human)) | BDBM290372 ((3R,4S)-3-amino-4-(3-boronopropyl)pyrrolidine-3-ca...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | PubMed | n/a | n/a | 113 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck & Co., Inc. Curated by ChEMBL | Assay Description Inhibition of human arginase1 in presence of DNTB by thio ornithine generation assay | ACS Med Chem Lett 11: 582-588 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Arginase-1 (Homo sapiens (Human)) | BDBM290372 ((3R,4S)-3-amino-4-(3-boronopropyl)pyrrolidine-3-ca...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Mars, Incorporated US Patent | Assay Description Inhibition of arginase I (ARG I) and arginase II (ARG II) by Formula I or Formula II compounds is followed spectrophotometrically at 530 nm. The comp... | US Patent US10603330 (2020) | |||||||||||
More data for this Ligand-Target Pair |